These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24145173)

  • 61. [Glioblastosis diffusa].
    FILIPOWICZ M; MOSSAKOWSKI M
    Neurol Neurochir Psychiatr Pol; 1955; 5(6):653-62. PubMed ID: 13309599
    [No Abstract]   [Full Text] [Related]  

  • 62. Cancer stem cells as a prognostic indicator for glioblastoma multiforme.
    Shabason JE; Camphausen K
    Biomark Med; 2010 Feb; 4(1):127-8. PubMed ID: 20387308
    [No Abstract]   [Full Text] [Related]  

  • 63. Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors.
    Yuan J; Zhang F; Hallahan D; Zhang Z; He L; Wu LG; You M; Yang Q
    J Exp Clin Cancer Res; 2021 Nov; 40(1):368. PubMed ID: 34794497
    [No Abstract]   [Full Text] [Related]  

  • 64. Letter to the Editor regarding "Clear-cell renal cell carcinoma and glioblastoma multiforme coexistence: Double primary malignancy, does it have a causal relationship?".
    Waack AL; Sharkey B; Hoyt A; Schroeder JL
    Surg Neurol Int; 2023; 14():134. PubMed ID: 37151470
    [No Abstract]   [Full Text] [Related]  

  • 65. Glioblastoma multiforme.
    Sheehan JM; Cavaliere R; Farace E; Bredel M; Burri SH
    Neurol Res Int; 2012; 2012():819304. PubMed ID: 22619716
    [No Abstract]   [Full Text] [Related]  

  • 66. Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage.
    Paranjpe A; Zhang R; Ali-Osman F; Bobustuc GC; Srivenugopal KS
    Carcinogenesis; 2014 Mar; 35(3):692-702. PubMed ID: 24193513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
    Kast RE; Karpel-Massler G; Halatsch ME
    Oncotarget; 2014 Sep; 5(18):8052-82. PubMed ID: 25211298
    [TBL] [Abstract][Full Text] [Related]  

  • 68. RIST: a potent new combination therapy for glioblastoma.
    Nonnenmacher L; Westhoff MA; Fulda S; Karpel-Massler G; Halatsch ME; Engelke J; Simmet T; Corbacioglu S; Debatin KM
    Int J Cancer; 2015 Feb; 136(4):E173-87. PubMed ID: 25123598
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The future of high-grade glioma: Where we are and where are we going.
    Le Rhun E; Rhun EL; Taillibert S; Chamberlain MC
    Surg Neurol Int; 2015; 6(Suppl 1):S9-S44. PubMed ID: 25722939
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurosurgery concepts: Key perspectives on dendritic cell vaccines, metastatic tumor treatment, and radiosurgery.
    Li G; Sherman JH; Cho JM; Lim M; Khalessi AA; Colen CB; Kim CY; Wang VY; Zada G; Smith ZA; Yang I
    Surg Neurol Int; 2015; 6():6. PubMed ID: 25657859
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect.
    Karpel-Massler G; Kast RE; Westhoff MA; Dwucet A; Welscher N; Nonnenmacher L; Hlavac M; Siegelin MD; Wirtz CR; Debatin KM; Halatsch ME
    J Neurooncol; 2015 Mar; 122(1):21-33. PubMed ID: 25524815
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
    Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
    Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Blocking the formation of radiation-induced breast cancer stem cells.
    Wang Y; Li W; Patel SS; Cong J; Zhang N; Sabbatino F; Liu X; Qi Y; Huang P; Lee H; Taghian A; Li JJ; DeLeo AB; Ferrone S; Epperly MW; Ferrone CR; Ly A; Brachtel EF; Wang X
    Oncotarget; 2014 Jun; 5(11):3743-55. PubMed ID: 25003837
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Potential Role of the Extracellular Matrix Glycoprotein Reelin in Glioblastoma Biology.
    Ongemach E; Zerrinius D; Heimann P; Wirtz CR; Debatin KM; Westhoff MA; Peraud A
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543187
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miRNA-194-3p represses NF-κB in gliomas to attenuate iPSC genes and proneural to mesenchymal transition.
    Jacob JR; Singh R; Okamoto M; Chakravarti A; Palanichamy K
    iScience; 2024 Jan; 27(1):108650. PubMed ID: 38226170
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Disulfiram in glioma: Literature review of drug repurposing.
    Zhong S; Shengyu Liu ; Xin Shi ; Zhang X; Li K; Liu G; Li L; Tao S; Zheng B; Sheng W; Ye Z; Xing Q; Zhai Q; Ren L; Wu Y; Bao Y
    Front Pharmacol; 2022; 13():933655. PubMed ID: 36091753
    [TBL] [Abstract][Full Text] [Related]  

  • 77. EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation.
    Guo G; Gong K; Beckley N; Zhang Y; Yang X; Chkheidze R; Hatanpaa KJ; Garzon-Muvdi T; Koduru P; Nayab A; Jenks J; Sathe AA; Liu Y; Xing C; Wu SY; Chiang CM; Mukherjee B; Burma S; Wohlfeld B; Patel T; Mickey B; Abdullah K; Youssef M; Pan E; Gerber DE; Tian S; Sarkaria JN; McBrayer SK; Zhao D; Habib AA
    Nat Cell Biol; 2022 Aug; 24(8):1291-1305. PubMed ID: 35915159
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Anti-Inflammatory Properties of Licorice (
    Leite CDS; Bonafé GA; Carvalho Santos J; Martinez CAR; Ortega MM; Ribeiro ML
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456938
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Natural Plant Compounds: Does Caffeine, Dipotassium Glycyrrhizinate, Curcumin, and Euphol Play Roles as Antitumoral Compounds in Glioblastoma Cell Lines?
    Bonafé GA; Boschiero MN; Sodré AR; Ziegler JV; Rocha T; Ortega MM
    Front Neurol; 2021; 12():784330. PubMed ID: 35300350
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma.
    Xu P; Westhoff MA; Hadzalic A; Debatin KM; Winiarski L; Oleksyszyn J; Wirtz CR; Knippschild U; Burster T
    ACS Omega; 2022 Feb; 7(7):5929-5936. PubMed ID: 35224353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.